Skip to content
LIVE
The Executives BriefThe Executives Brief

Companies sit on $10.5tn of goodwill, and rates are coming for it

A global M&A boom has stacked $10.5tn of goodwill onto corporate balance sheets, and Nikkei Asia flags interest rate risk as the trigger that could turn that cushion into a writedown.

ByHessa Al-FalehBusiness Desk, The Executives Brief
·3 min read
Companies sit on $10.5tn of goodwill, and rates are coming for it
Executive summary

Global goodwill assets have climbed to $10.5tn on the back of an M&A boom, Nikkei Asia reports, with interest rate risk now hanging over the value of those assets. For CFOs and boards, the exposure is not the cash already spent on deals but the earnings hit, covenant pressure, and credibility damage an impairment cycle could deliver.

Goodwill is the accounting plug for the premium a buyer pays above the fair value of a target's identifiable net assets, and there is now $10.5 trillion of it sitting on corporate balance sheets worldwide, according to Nikkei Asia. That number is the residue of an M&A boom. Every deal struck at a price above book value leaves a line on the acquirer's balance sheet representing the stuff you cannot touch: brand, customer relationships, a trained workforce, and the synergies the buyer promised shareholders. It is not cash. It cannot be sold separately. It is a bet, capitalised and parked in the accounts.

The second half of the Nikkei headline is the part that should keep finance chiefs awake: interest rate risk looms. Goodwill does not get amortised on a schedule the way a factory or a patent does. Under both IFRS and US GAAP it sits there until the company runs an annual impairment test, which in practice means discounting the expected future cash flows of the business unit that goodwill belongs to. Raise the discount rate and the present value of those cash flows falls. Raise it enough, and the number drops below the carrying value on the balance sheet, and the difference gets written off through the income statement. The same rate move that cooled the deal market is now threatening the assets the deal market created.

The mechanics matter because they are slow and then sudden. Impairment testing is done at the level of a cash-generating unit, and the headroom between carrying value and recoverable amount is often thinner than boards assume. A single percentage point on a discount rate can erase years of projected growth in a terminal value calculation. Historically, big goodwill writeoffs cluster in downturns rather than build up gradually, which is why they land as shocks: the dot-com unwind, the financial crisis, and the pandemic year each produced waves of charges as assumptions were reset all at once. The trigger is rarely a single bad quarter. It is a change in the rate used to value the future.

For a board, the awkward part is that impairment is a non-cash charge that behaves very much like a cash problem. It does not drain the bank account, but it hits reported earnings per share, it can push a company through a leverage covenant tied to EBITDA or tangible net worth, and it frequently lands on the same metrics that management incentive plans are built around. It also arrives late. Equity markets tend to price the doubt long before the auditor signs off, which means the writeoff confirms a suspicion rather than breaking news. By the time the charge is disclosed, the credibility cost is already paid.

The composition of the boom amplifies the risk. When competition for assets is fierce, buyers pay more of the price as goodwill and less as identifiable, depreciable assets. That flatters near-term earnings, because goodwill is not amortised and does not generate the depreciation charge a heavy asset base would. It concentrates risk instead. Serial acquirers, private equity roll-ups, and any company that grew by buying growth in technology, healthcare, or media typically carry the highest goodwill-to-equity ratios, and those are precisely the portfolios where a higher cost of capital bites hardest, because the value of a fast-growing business is weighted toward distant cash flows that discount rates punish most.

Expect the pressure to show up first in disclosure. Auditors who have spent the past few years defending optimistic terminal growth assumptions will be harder to convince when the risk-free rate has moved. Regulators have long pushed for clearer sensitivity analysis around discount rates and long-term growth, and investors have learned to read the gap between goodwill and market capitalisation as a warning sign. Activist shareholders use it as a screen. Lenders use it to justify tighter terms. Analysts use it to argue that reported returns on capital are overstated.

The strategic stakes are straightforward for anyone who has closed a deal in the past five years. Goodwill is a promise about the future written into the accounts, and the discount rate is the price of that promise. CFOs who can show a board the sensitivity of each cash-generating unit to a higher rate, who disclose assumptions before auditors force the issue, and who can explain which acquisitions are carrying the most fragile headroom will be the ones who keep control of the narrative when the cycle turns. The $10.5tn is not a scandal. It is a very large, very quiet bet that rates stay friendly, and the bill for being wrong shows up in one line.

Executive ActionsLocked

This story's Key Insights and Take-aways are locked.

Create a free account to unlock Executive Actions for one credit.

Register to Unlock

Always free for Executives Club members. Join the Club

More in Business